FIELD: medicine. SUBSTANCE: agent has the following components: acetylsalicylic acid and carbacycline derivative of prostaglandin - eptaloprost ((5E)-(16S)-13,14-didehydro-1a,1b-dihomo-16,20-di- -methyl-3-oxa-18,18,19,19-tetrahydro-6a-carbaprostaglandin--I2) or cycaprost ((5E)-(16S)-16,20-dimethyl-3-oxa-13,14,18,18,19,19-hexahydro- -6a-carbaprostaglandin--I2) at mass ratio of acetylsalicylic acid and the indicated carbacycline derivative = (1: 5 x 10-6)-(1:1). EFFECT: enhanced effectiveness of agent. 4 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TUMOR METASTASIS TREATMENT | 1990 |
|
RU2112514C1 |
| METHOD FOR PREPARING CYCLODEXTRIN CLATHRATE - ANALOG OF CARBACYCLINE | 0 |
|
SU1632371A3 |
| METHOD FOR PRODUCING DERIVATIVES OF CARBACYCLINES OR THEIR ADDITIVE-BASIC SALTS OF TRIS-(OXYMETHYL)-AMINOMETHAN | 0 |
|
SU1316555A3 |
| METHOD OF PRODUCING DERIVATIVES OF (5E)-13,14,18,19,19-HEXADEHYDRO-3-OXA-6A-CARBOPROSTAGLANDIN-1 SUB TWO OR SALTS THEREOF | 0 |
|
SU1384196A3 |
| METHOD OF OBTAINING CARBACYCLINE DERIVATIVES OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS | 0 |
|
SU1145926A3 |
| METHOD OF PRODUCING DERIVATIVES OF CARBACYCLINE | 0 |
|
SU1367856A3 |
| METHOD OF PRODUCING CARBOCYCLINE DERIVATIVES OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF | 0 |
|
SU1380608A3 |
| METHOD OF PRODUCING 5-CYANOPROSTACYCLINES | 0 |
|
SU1450739A3 |
| METHOD FOR TREATING THE CASES OF CHRONIC POLYARTHRITIS | 1993 |
|
RU2179023C2 |
| PROCESS FOR PREPARING 17-OXOSTEROIDS | 1991 |
|
RU2082762C1 |
